Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation

Conditions:   Extracorporeal Membrane Oxygenation Complication;   Anticoagulants Interventions:   Drug: Bivalirudin;   Drug: Unfractionated heparin Sponsors:   Legacy Health System;   Pacific University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Angiomax | Research